{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:52:03Z","timestamp":1790099523088,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.thromres.2018.01.032","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T14:17:53Z","timestamp":1517581073000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications"],"prefix":"10.1016","volume":"163","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-3310","authenticated-orcid":false,"given":"Jihyun","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngil","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su jong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.thromres.2018.01.032_bb0005","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.27546","article-title":"Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study","volume":"61","author":"Nery","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.thromres.2018.01.032_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1365-2036.2009.04182.x","article-title":"Systematic review: portal vein thrombosis in cirrhosis","volume":"31","author":"Tsochatzis","year":"2010","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.thromres.2018.01.032_bb0015","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hep.1840160515","article-title":"The incidence of portal vein thrombosis at liver transplantation","volume":"16","author":"Nonami","year":"1992","journal-title":"Hepatology"},{"issue":"9\u201312","key":"10.1016\/j.thromres.2018.01.032_bb0020","first-page":"583","article-title":"Coagulation abnormalities in cirrhotic patients with portal vein thrombosis","volume":"53","author":"Amitrano","year":"2007","journal-title":"Clin. Lab."},{"issue":"6","key":"10.1016\/j.thromres.2018.01.032_bb0025","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood-2010-02-261891","article-title":"Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences","volume":"116","author":"Lisman","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2018.01.032_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2018.01.032_bb0035","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jhep.2015.07.040","article-title":"EASL Clinical Practice Guidelines: vascular diseases of the liver","volume":"64","author":"e.e.e. European Association for the Study of the Liver","year":"2016","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.thromres.2018.01.032_bb0040","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br. J. Surg."},{"issue":"4","key":"10.1016\/j.thromres.2018.01.032_bb0045","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"15","key":"10.1016\/j.thromres.2018.01.032_bb0050","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study","volume":"319","author":"S. North Italian Endoscopic Club for the","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.thromres.2018.01.032_bb0055","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3748\/wjg.v16.i2.143","article-title":"Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment","volume":"16","author":"Ponziani","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.thromres.2018.01.032_bb0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","article-title":"Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators","volume":"38","author":"D'Amico","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.thromres.2018.01.032_bb0065","first-page":"1072A","article-title":"Portal vein thrombosis in cirrhotic patients is associated with advanced liver disease and predicts poor long term prognosis","volume":"52","author":"Ferreira","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.thromres.2018.01.032_bb0070","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1111\/j.1600-6143.2008.02400.x","article-title":"Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation","volume":"8","author":"Rana","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.thromres.2018.01.032_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/lt.21941","article-title":"Portal vein thrombosis and survival in patients with cirrhosis","volume":"16","author":"Englesbe","year":"2010","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1016\/j.thromres.2018.01.032_bb0080","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","author":"Francoz","year":"2005","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.thromres.2018.01.032_bb0085","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/ajg.2012.452","article-title":"De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes","volume":"108","author":"Maruyama","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.thromres.2018.01.032_bb0090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1148\/radiol.12112236","article-title":"Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis","volume":"265","author":"Luca","year":"2012","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.thromres.2018.01.032_bb0095","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic passive venous congestion drives hepatic fibrogenesis via sinusoidal thrombosis and mechanical forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.thromres.2018.01.032_bb0100","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.thromres.2018.01.032_bb0105","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.thromres.2018.01.032_bb0110","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","author":"Werner","year":"2013","journal-title":"Dig. Dis. Sci."},{"issue":"1","key":"10.1016\/j.thromres.2018.01.032_bb0115","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","author":"Chen","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.thromres.2018.01.032_bb0120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1478-3231.2011.02489.x","article-title":"Towards a rational use of low-molecular-weight heparin in patients with cirrhosis","volume":"31","author":"Lisman","year":"2011","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.thromres.2018.01.032_bb0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","author":"Bechmann","year":"2011","journal-title":"Liver Int."},{"issue":"29","key":"10.1016\/j.thromres.2018.01.032_bb0130","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.4254\/wjh.v7.i29.2906","article-title":"Therapeutic and clinical aspects of portal vein thrombosis in patients with cirrhosis","volume":"7","author":"Primignani","year":"2015","journal-title":"World J. Hepatol."},{"issue":"6","key":"10.1016\/j.thromres.2018.01.032_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","author":"Amitrano","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"issue":"7","key":"10.1016\/j.thromres.2018.01.032_bb0140","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.thromres.2018.01.032_bb0145","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","author":"Senzolo","year":"2012","journal-title":"Liver Int."},{"issue":"8","key":"10.1016\/j.thromres.2018.01.032_bb0150","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","author":"Cui","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.thromres.2018.01.032_bb0155","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MEG.0000000000000790","article-title":"Role of low-molecular-weight heparins in prevention of thromboembolic complication after transarterial chemoembolization in hepatocellular carcinoma","volume":"29","author":"Negm","year":"2017","journal-title":"Eur. J. Gastroenterol. Hepatol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384818300410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T20:56:43Z","timestamp":1660424203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384818300410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":31,"alternative-id":["S0049384818300410"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2018.01.032","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2018.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}